The timeline varies depending on the nature of the consultation. We aim to respond within two days of receiving your request.

It can be executed concurrently upon the client’s request.

CND is not a GLP testing facility. We provide consulting on a broad range of issues related to nonclinical drug development, as well as toxicologic pathology evaluation services.

Please submit a brief inquiry, and CND will contact you to discuss the details and arrange an appropriate schedule and consultation method—by phone, email, video conference, or an in-person meeting.

Please submit an inquiry, and we will contact you to arrange the details. Glass slides may be delivered by mail, courier service, express delivery, or in person. Whole-slide images (WSIs) may be provided by email, external hard drive, or another mutually agreed method.

Yes, certainly. We also provide consultation on a wide range of in vitro studies in addition to animal studies.

Consulting fees are determined through mutual discussion based on the scope and scale of the requested services.

Yes. We review and provide consultation on documents intended for submission to both Korean and international regulatory authorities.

Yes. All consultation materials are prepared to a standard suitable for submission to regulatory authorities.

Yes, of course. We work with both large pharmaceutical companies and small biotechnology companies.